Pregnancy
A “modifiable” risk factor in MS?
Citation Manager Formats
Make Comment
See Comments

This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
In the first half of the 20th century, some women with multiple sclerosis (MS) were advised by their neurologist not to become pregnant, or even to have a therapeutic abortion if they did.1 However, now it is widely accepted that relapse rate is reduced during pregnancy, at least in the second and third trimester. Furthermore, there is no evidence that pregnancy is associated with negative long-term consequences and some studies have actually suggested beneficial effects.2,3
Studies of the effect of pregnancy on MS disease course are confounded by effects of disease severity on the decision of whether to become pregnant. Those with less severe disease reasonably might be expected to choose to become pregnant more often than those with more severe disease due to the fear of not being able take care of a child. An elegant approach to circumventing this confound was undertaken in the study by Ponsonby and colleagues4 in this issue of Neurology® by confining their analysis to persons with a first demyelinating event. In this study of 282 Australian cases and 542 controls, recruited from several sites, they found that the number of pregnancies was inversely associated with the risk of having a first demyelinating event. They concluded that this was consistent with a cumulative effect of pregnancy to reduce the risk of developing MS to one-fourth of the nulliparous risk for those with 3 or more pregnancies, and to one-20th for those with 5 or more pregnancies. Although case-control studies are prone to confounding, the authors considered a number of genetic and environmental confounders, including HLA type and sun exposure, among others, and none seemed to explain the observations.
Another important conclusion from this work was that prenatal biologic factors in the mother, not postnatal environmental factors that would …
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Letters: Rapid online correspondence
REQUIREMENTS
If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Use of Whole-Genome Sequencing for Mitochondrial Disease Diagnosis
Dr. Robert Pitceathly and Dr. William Macken
► Watch
Related Articles
Topics Discussed
Alert Me
Recommended articles
-
Article
High risk of postpartum relapses in neuromyelitis optica spectrum disorderEric C. Klawiter, Riley Bove, Liene Elsone et al.Neurology, November 01, 2017 -
Article
Pregnancy in Patients With AQP4-Ab, MOG-Ab, or Double-Negative Neuromyelitis Optica DisorderNicolas Collongues, Cecilia Alves Do Rego, Bertrand Bourre et al.Neurology, February 24, 2021 -
Article
Pregnancy outcomes in aquaporin-4–positive neuromyelitis optica spectrum disorderMatthew M. Nour, Ichiro Nakashima, Ester Coutinho et al.Neurology, November 18, 2015 -
Articles
Neuromyelitis optica and pregnancyB. Bourre, R. Marignier, H. Zéphir et al.Neurology, March 07, 2012